XML 52 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
SCHEDULE II
AMGEN INC.
VALUATION AND QUALIFYING ACCOUNTS
Years ended December 31, 2024, 2023 and 2022
(In millions)
Allowance for doubtful accountsBalance
at beginning
of period		Additions
charged to
costs and
expenses		Other
additions		DeductionsBalance
at end
of period
2024
$28 $13 $— $(3)$38 
2023
$22 $6 $— $— $28 
2022
$26 $— $— $(4)$22